US-based health and wellness company Mangoceuticals (MangoRx) has secured a patent for its mushroom-derived compositions and methods of treatment.
MangoRx is focused on developing, marketing, and selling men’s health and wellness products through its secure telemedicine platform.
The new patent includes nutraceuticals derived from functional mushrooms, including Cordyceps sinensis, Ganoderma lucidum (Reishi), and Hericium erinaceus (Lion’s Mane).
The formulations deliver health benefits including enhanced immune function, cognitive performance, mood and mental clarity, antioxidant benefits, and suppressed appetite.
Also, the patent highlights the flexibility of the formulations, enabling the combination of these compounds in specific dosages to enhance synergistic effects.
MangoRx founder and CEO Jacob Cohen said: “This acquisition is a significant step forward in our mission to provide cutting-edge wellness solutions.
“We believe that the unique properties of these mushroom-derived formulations offer tremendous potential for products that can address a wide spectrum of health concerns, from immune support to cognitive enhancement.”
MangoRx intends to use the new patent to research and develop a new line of wellness products including dietary supplements and functional foods.
The planned products include daily immune support supplements using the antioxidant properties of Reishi and Chaga mushrooms.
The products include supplements featuring Lion’s Mane for brain function and nerve health and stress resilience formulas using Cordyceps to manage stress and boost energy levels.
Weight management aids will incorporate appetite-suppressing and metabolism-supporting properties of these mushroom compounds.
MangoRx also plans to differentiate its offerings by prioritising stringent ingredient validation, ensuring each product meets the highest standards of efficacy and quality.
The unique formulations aim to address the growing demand for adaptogens and functional supplements that support long-term health and well-being, said MangoRx.
